Vea Health Review
Best for: Men interested in a longevity + performance + weight-loss bundled telehealth platform who are comfortable with limited pricing transparency upfront and a men's-health-first brand positioning, and who want to read the FDA compounded-medication disclaimer before purchasing.
Vea Health (veahealth.co) is a direct-to-consumer telehealth platform positioning itself in the men's health + performance + longevity niche, offering compounded semaglutide and tirzepatide in both oral and injection protocols. The platform self-describes as 'personalized telehealth' for 'high-performers' targeting weight loss, anti-aging, sexual health, and metabolic health under one umbrella. Says it serves 'all 50 states' via 'doctors & clinicians in all 50 states'. The platform publishes a verbatim FDA compounded-medication disclaimer: 'Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality.' Pricing is NOT disclosed on the homepage (gated behind sign-up flow). Pharmacy partner, LegitScript ID, 503A vs 503B designation, named medical director, governing law, and refund policy are also NOT disclosed in publicly accessible content. Live-verified 2026-05-19.
Medium confidence · Last verified 2026-05-19 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Vea Health is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Vea Health prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
✓ Pros
- •Verbatim FDA compounded-medication disclaimer published — unusual transparency
- •Oral AND injection protocols offered for both semaglutide and tirzepatide
- •Claims 50-state coverage via clinician network
- •Brand positioning is clearly differentiated (longevity + men's health + performance) vs generic DTC GLP-1
✗ Cons
- •Pricing NOT disclosed on the public homepage — gated behind sign-up flow
- •Pharmacy partner NOT named — only 'U.S.-based pharmacy' framing
- •LegitScript certification status NOT visible on homepage
- •Named medical director NOT disclosed
- •503A vs 503B designation NOT specified
- •Corporate legal entity (LLC/Inc/PC) NOT disclosed
- •Men's-health-first positioning may not align with women's weight-loss audience
Ready to start with Vea Health?
See current pricing and start your free consultation.
Sources & methodology
Our Vea Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Vea Health
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Vea Health?
See current pricing and start your free consultation.